Brisbane, Australia - 4 June 2015 - Clinical Network Services (CNS), an integrated service group focused on clinical product development and headquartered in Australia with offices in New Zealand, the UK and the USA, has announced that it has been voted as Australia’s favourite CRO for 2015 by the foremost membership and professional development association, ARCS Australia Ltd.
The award, presented to CNS during the 2015 ARCS Scientific Congress in Sydney, was based on votes from international and local sponsors as well as local investigational sites. ARCS Australia Ltd, (previously the Association of Regulatory and Clinical Scientists) is a professional development association for people working in the development of therapeutic goods. Presenting the award, ARCS CEO, Adrian Bootes stated “ARCS would like to help recognise the efforts of those working in the development of therapeutics by awarding companies and sites, as nominated by their peers. Being chosen as the Favourite CRO wasn’t simply a reflection of CNS’s systems and processes, but was also an acknowledgment of the people, who are the essential glue.”
Chief Operating Officer, Gabrielle McKee commented: “CNS is proud and honoured to have won this award. As a company, CNS has always been committed to maintaining a positive culture focused on how we interact with each other, our clients and importantly the wonderful clinicians, co-ordinators and pharmacists who are at the forefront of delivering our trials to patients.”
“This is a very special award for CNS” added CNS’ Managing Director, Russell Neal. “We have never been a group motivated by the limelight or winning awards, but recognition from those we work with every day is a wonderful validation of the emphasis CNS places in our working relationships, whether that be with our site colleagues, our clients and indeed with each other. It’s the personal touch that continues to underpin CNS’ growth & success.”
CNS would like extend a thank you to all those who voted for CNS and to ARCS for hosting this award.
About Clinical Network Services
Clinical Network Services (CNS) is an integrated service group focused on product development headquartered in Australia with offices in New Zealand, the UK and the USA, who create value for small-medium sized biotechnology companies by progressing early stage products through phase 1 & 2 clinical trials or the marketplace sooner. CNS offers a unique service where it integrates BioDesk, an intelligent global product development and regulatory affairs consultancy, with our committed, highly experienced Australian/New Zealand clinical services and biometrics team. CNS’ regional clinical advantage is driven by the extremely pragmatic regulatory environment in Australia and New Zealand that makes it possible for clients to enter the clinic quickly, without prior regulatory approval.
CNS offers a uniquely differentiated, customer-orientated, suite of services to clients which enables CNS to guide products efficiently through critical post-discovery development and into initial human trials. Throughout, CNS takes a global development/ regulatory strategic approach to ensure that value is added at every stage of the product development life cycle.
Further information about CNS and its intelligent development services can be found at www.clinical.net.au
Issued for and on behalf of Clinical Network Services by Instinctif Partners.
For more information please contact: CNS@instinctif.com